ACE2 and hypertrophic cardiomyopathy: We were particularly concerned about outcomes of patients with hypertrophic cardiomyopathy (HCM) due to reports of ACE2 gene upregulation in septal myectomy specimens (7) — the ACE2 receptor being the entry point for the SARS-CoV-2 virus.